<html><head></head><body><h1>Calcium Salts</h1><p class="drug-subtitle"><b>Class:</b> Replacement Preparations<br/>
- Antidotes<br/>
<b>VA Class:</b> TN420<br/>
<b>CAS Number:</b> 543-90-8<br/>
<b>Brands:</b> Alka-Mints, Calci-Chew, Calci-Mix, Caltrate, Chooz, Citracal, Liqui-Cal, Os-Cal, PhosLo, Posture, Posture-D, Titralac, Tums</p><ul class="ddc-anchor-links"><li>Uses</li>
<li>Dosage</li>
<li>Cautions</li>
<li>Interactions</li>
<li>Pharmacokinetics</li>
<li>Patient advice</li>
<li>Preparations</li></ul><h3>Warning</h3><ul>Pharmacy Bulk Packages
<li>
<p>Pharmacy bulk packages are for preparation of IV mixtures <i>only</i>.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;g&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
<li>
<p><i>Not</i> for direct IV infusion.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;g&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
</ul><p>Pharmacy bulk packages are for preparation of IV mixtures <i>only</i>.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;g&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p><i>Not</i> for direct IV infusion.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;g&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h2>Introduction</h2><p>Calcium salts are used as a source of calcium, an essential nutrient cation.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h2 class="ddc-anchor-offset" id="uses">Uses for Calcium Salts</h2><h3>Dietary Requirements (oral therapy)</h3><p>For maintaining an adequate intake of calcium to support the development and preservation of bone mass at a level sufficient to prevent fractures associated with osteopenia or osteoporosis in later life and of other calcified tissues (e.g., teeth).&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;126&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;129&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;147&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;153&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Life long intake of adequate calcium is necessary for good bone health at any age; calcium requirements may increase among older individuals.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;147&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;148&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Adequate intakes of calcium can be accomplished through changes in food consumption behaviors, consumption of nutrient-fortified foodstuffs, use of dietary supplements, or a combination of these.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;147&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;153&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>In the US and Canada, calcium principally is obtained from dairy products.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; Other principal sources include fruits, vegetables, and grain products.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; In addition, many healthy individuals take dietary supplements containing calcium.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>For specific information on currently recommended Dietary Reference Intakes (DRIs) of calcium for various life-stage and gender groups, see Dosage under Dosage and Administration.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Hypocalcemia (parenteral and oral therapy)</h3><p>Calcium salts are used as a source of calcium cation for the treatment or prevention of calcium depletion when dietary measures are inadequate.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; Conditions associated with calcium deficiency include hypoparathyroidism, achlorhydria, chronic diarrhea, vitamin D deficiency, steatorrhea, sprue, pregnancy and lactation, menopause, pancreatitis, renal failure, alkalosis, and hyperphosphatemia.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Some clinicians consider IV calcium chloride the calcium salt of choice to prevent hypocalcemia during transfusions with citrated blood.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; In addition to being irritating, however, the chloride salt is acidifying and generally should not be used when acidosis coincides with hypocalcemia (e.g., renal failure).&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>The calcium glycerophosphate and calcium lactate fixed-combination injection is used IM to increase serum calcium concentrations.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;142&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Administration of certain drugs (e.g., some diuretics, anticonvulsants) may sometimes result in hypocalcemia, which may warrant calcium replacement therapy.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium is administered in long-term electrolyte replacement regimens.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Use of calcium salts should not preclude the use of other measures intended to correct the underlying cause of calcium depletion.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Vitamin D analogs may be administered concomitantly with oral calcium salts for the treatment of chronic hypocalcemia, especially when caused by vitamin D deficiency.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium salts may be used orally for the treatment of hypocalcemia secondary to the administration of anticonvulsant drugs.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Hypocalcemic Tetany (IV therapy)</h3><p>IV calcium gluconate is considered the salt of choice for the treatment of acute hypocalcemia.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium salts are used to treat acute hypocalcemic tetany secondary to renal failure, hypoparathyroidism, premature delivery, and/or maternal diabetes mellitus in infants, and poisoning with magnesium, oxalic acid, radiophosphorus, carbon tetrachloride, fluoride, phosphate, strontium, or radium.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Hypoparathyroidism, Chronic (oral therapy)</h3><p>Calcium salts may be used for treatment of chronic hypoparathyroidism.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Latent Tetany (oral therapy)</h3><p>Calcium salts may be used for the treatment of latent tetany.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Osteoporosis (oral therapy)</h3><p>Calcium salts (e.g., calcium carbonate, calcium citrate) are used as supplements in the prevention and treatment of osteoporosis when dietary intake of calcium is insufficient.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;147&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;148&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Adequate intake of calcium and vitamin D (which increases absorption of calcium) is universally recommended for all individuals to diminish age-related bone loss and prevent osteoporosis.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;147&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;148&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>In addition to lifestyle modifications (e.g., regular weight-bearing exercise, avoidance of excessive alcohol and tobacco use), the National Osteoporosis Foundation recommends a daily calcium intake of 1 g in men 50–70 years of age, and 1.2 g in women ≥51 years of age and men ≥71 years of age.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;147&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>The combination of calcium and vitamin D has been shown to reduce risk of fractures.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;147&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Glucocorticoid-induced Osteoporosis (oral therapy)</h3><p>Calcium salts are used for prevention of glucocorticoid-induced osteoporosis.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;622&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>The American College of Rheumatology (ACR) recommends optimizing dietary intake of calcium (1–1.2 g daily) and vitamin D (600–800 units daily) in all patients receiving long-term glucocorticoid therapy (defined as a daily dosage equivalent to 2.5 mg of prednisone or greater for ≥3 months).&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;622&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Because of concerns about potential harms (e.g., cardiovascular risks), ACR states that additional study is needed to determine potential benefits versus risks of calcium and vitamin D supplementation in patients receiving glucocorticoids.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;622&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Osteomalacia (oral therapy)</h3><p>Calcium salts may be used for treatment of osteomalacia.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Anticonvulsant-induced Hypocalcemia (oral therapy)</h3><p>Calcium salts may be used for treatment of rickets, latent tetany, and hypocalcemia secondary to the administration of anticonvulsant drugs.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Rickets (oral therapy)</h3><p>Calcium salts may be used for treatment of rickets.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Hyperphosphatemia in Chronic Renal Failure (oral therapy)</h3><p>Calcium acetate and calcium carbonate are considered the salts of choice for chronic renal failure.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;126&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>In addition to providing a source of calcium, calcium acetate or carbonate sequesters phosphate in the intestine by forming insoluble phosphates that are excreted fecally, thus reducing serum phosphate concentrations and secondary hyperparathyroidism.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium carbonate partially corrects metabolic acidosis which may occur in chronic renal failure.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Because of the risk of aluminum accumulation and resultant neurotoxic and osteomalacic effects, most clinicians no longer use aluminum hydroxide to inhibit phosphorus absorption; instead calcium acetate or carbonate and/or non-calcium-, non-aluminum-, non-magnesium-containing phosphate binders (e.g., lanthanum carbonate, sevelamer hydrochloride) currently are used.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;127&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;130&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;131&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;132&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>When taken with meals, calcium acetate or carbonate can contribute to controlling hyperphosphatemia in chronic renal failure by binding to and inhibiting absorption of phosphates in the GI tract.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;127&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Exercise caution in patients undergoing chronic hemodialysis to prevent hypophosphatemia.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Patients with end-stage renal failure may develop hypercalcemia when calcium is administered with meals; do not give calcium supplementation concomitantly when calcium salts are used to control hyperphosphatemia in such patients.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Progressive hypercalcemia secondary to overdose of calcium salts can occur and may require emergency treatment measures.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Chronic hypercalcemia also may lead to vascular and other soft-tissue calcification;&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;126&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; periodic (e.g., twice weekly) monitoring of calcium concentrations is recommended during the initial dose adjustment.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; One manufacturer recommends that the serum calcium times phosphate (Ca × P) product should not exceed 66.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; Radiographic evaluation of a suspected anatomical region for early soft-tissue calcification may be useful.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Advanced Cardiovascular Life Support (IV therapy)</h3><p>Because of the lack of demonstrated benefit and potential for detrimental effects, calcium should not be used routinely during cardiac arrest unless there is documented hypocalcemia, calcium-channel blocker toxicity, hypermagnesemia, or hyperkalemia.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;196&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;400&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;401&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;403&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; When used in this setting, either calcium chloride or calcium gluconate may be administered.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;403&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Aminoglycoside Neuromuscular Blockade (IV therapy)</h3><p>Calcium salts are used to antagonize neuromuscular blockade† resulting from the use of aminoglycoside antibiotics (e.g., gentamicin, kanamycin, neomycin) with or without agents possessing neuromuscular blocking properties (e.g., gallamine triethiodide).&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Magnesium Intoxication (IV therapy)</h3><p>Calcium gluconate may be used in the treatment of magnesium sulfate overdosage.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;196&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;c&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Myasthenia Gravis (oral therapy)</h3><p>Calcium salts are used as adjunctive treatment of myasthenia gravis.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>In general, any oral calcium salt may be used for chronic replacement therapy.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Medullary Thyroid Carcinoma (IV therapy)</h3><p>Calcium infusions (“calcium challenge”) are used in medullary thyroid carcinoma†.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Acid Indigestion (oral therapy)</h3><p>Calcium carbonate or phosphate may be used for <i>self-medication</i> for the relief of acid indigestion, heartburn, and sour stomach.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;d&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Colic, Renal, Biliary, Intestinal, or Lead (IV and IM therapy)</h3><p>Calcium salts have been used IM or IV as adjunctive therapy to reduce spasms in renal, biliary, intestinal, or lead colic.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Zollinger-Ellison Syndrome, Diagnosis (IV therapy)</h3><p>Calcium infusions (“calcium challenge”) are used to diagnose the Zollinger-Ellison syndrome†.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Eaton-Lambert Syndrome (oral therapy)</h3><p>Calcium salts are used as adjunctive treatment of the Eaton-Lambert syndrome.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>In general, any oral calcium salt may be used for chronic replacement therapy.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Insect Bites and Other Sensitivity Reactions (IV therapy)</h3><p>Calcium salts have been used IV as adjuncts to relieve muscle cramps in the treatment of insect bites or stings (e.g., black widow spider) or to decrease capillary permeability in sensitivity reactions characterized by urticaria or angioedema and in allergic conditions, including nonthrombocytopenic purpura, dermatitis herpetiformis, drug-induced pruritus, hay fever, and asthma.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Preeclampsia (oral therapy)</h3><p>Although some evidence suggested a beneficial effect of calcium supplementation on preeclampsia,&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;117&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;118&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;125&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; a large, well-designed study did <i>not</i> confirm a beneficial effect of calcium supplementation in preventing preeclampsia during pregnancy.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;117&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; However, these findings do not obviate adequate dietary calcium intake during pregnancy nor do they address whether adequate or increased calcium intake can affect blood pressure favorably in pregnant women.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;105&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;118&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;125&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>β-Adrenergic or Calcium-channel Blocking Agent Overdosage (IV therapy)</h3><p>Some experts state that calcium salts may be considered in the treatment of calcium-channel blocking agent-induced toxicity.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;403&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Also may be useful in the treatment of β-adrenergic blocking agent toxicity in patients with shock refractory to other treatment measures.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;196&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Diuresis (oral therapy)</h3><p>Calcium chloride, an acid-forming salt, has been used to promote diuresis, however, because it is irritating and loses effectiveness after a few days, it is rarely used for this effect.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h2 class="ddc-anchor-offset" id="dosage">Calcium Salts Dosage and Administration</h2><h3>Administration</h3><p>Administer calcium orally (as acetate, carbonate, citrate, gluconate, lactate, or phosphate salt) or IV (as chloride or gluconate salt).&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;j&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>The fixed combination of calcium glycerophosphate and calcium lactate is injected IM.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;142&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium chloride also may be administered by intraosseous (IO) injection† during pediatric resuscitation; onset of action and systemic concentrations are comparable to those achieved with venous administration.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;403&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Administer acetate, carbonate, citrate, gluconate, lactate, and phosphate salts of calcium orally.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Administer most oral calcium supplements 1–1.5 hours after meals or with a demulcent (e.g., milk).&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; However, calcium carbonate powder generally should be administered with meals, since mixing the powder with food for administration is recommended.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium salts used to bind dietary phosphate in patients with end-stage renal disease should be administered with meals (e.g., 10–15 minutes before, or during, the meal).&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;130&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>For solution and drug compatibility information, see Compatibility under Stability.</p><p>Calcium chloride or gluconate may be administered IV.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;j&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium gluconate usually is administered IV as a 10% solution and calcium chloride as a 2–10% solution.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;j&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>When injected IV, administer calcium salts slowly through a small needle into a large vein to avoid too rapid an increase in serum calcium and extravasation of calcium solution into the surrounding tissue with resultant necrosis.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Following IV injections, the patient should remain recumbent for a short time.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Close monitoring of serum calcium concentrations is essential during IV administration of calcium.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Children: Calcium salts should not be administered through scalp veins; oral administration of calcium supplements or calcium-rich foods should replace IV calcium therapy as soon as possible.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Usually, administer IV undiluted.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;a&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;c&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Parenteral calcium salts also may be administered in a compatible large-volume IV infusion fluid.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; (See Solution Compatibility under Compatibility.)</p><p>Pharmacy bulk packages are for preparing IV admixtures only.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;g&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Administer IV calcium injections slowly at a rate not exceeding 0.7–1.8 mEq/minute.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Stop the injection if the patient complains of discomfort.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Pharmacy bulk packages must <i>not</i> be infused IV directly.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;g&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Administer pediatric dose for CPR by slow IV injection over 10–20 seconds.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p><i>Calcium chloride should not be injected IM or into subcutaneous or perivascular tissue, since severe necrosis and sloughing may occur.</i>&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Although other calcium salts may cause mild to severe local reactions, they generally are less irritating than calcium chloride.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; (See Cautions.)</p><p>Although some manufacturers previously stated that calcium gluconate could be injected IM when IV administration was not possible,&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; manufacturers of calcium gluconate currently state that the drug should not be injected IM or into subcutaneous tissue because of the potential for severe local reactions.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;140&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;141&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>The fixed-combination of calcium glycerophosphate and calcium lactate is injected IM.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;142&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Dosage</h3><p>Dosage of the oral calcium supplements usually is expressed in g or mg of elemental calcium and depends on the requirements of the individual patient.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Dosage of parenteral calcium replacements usually is expressed as mEq of calcium and depends on individual patient requirements.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>One mEq of elemental calcium is equivalent to 20 mg.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>The calcium content of the various calcium salts is approximately:&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium Salt</p><p>Calcium Content</p><p>calcium acetate</p><p>253 mg (12.7 mEq) per g</p><p>calcium carbonate</p><p>400 mg (20 mEq) per g</p><p>calcium chloride</p><p>270 mg (13.5 mEq) per g</p><p>calcium citrate</p><p>211 mg (10.6 mEq) per g</p><p>calcium gluceptate</p><p>82 mg (4.1 mEq) per g</p><p>calcium gluconate</p><p>90 mg (4.5 mEq) per g</p><p>calcium glycerophosphate</p><p>191 mg (9.6 mEq) per g</p><p>calcium lactate</p><p>130 mg (6.5 mEq) per g</p><p>calcium phosphate dibasic anhydrous</p><p>290 mg (14.5 mEq) per g</p><p>calcium phosphate dibasic dihydrate</p><p>230 mg (11.5 mEq) per g</p><p>calcium phosphate tribasic</p><p>400 mg (20 mEq) per g</p><p>Oral calcium supplements usually are administered in 3 or 4 divided doses daily.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Optimum calcium absorption may require supplemental vitamin D in individuals with inadequate vitamin D intake, those with impaired renal activation of the vitamin, or those not receiving adequate exposure to sunlight.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;116&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Dietary reference intake values for elemental calcium currently recommended by the National Academy of Sciences (NAS) in healthy children are as follows.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;153&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; Adequate intakes (AIs) are given for infants &lt;1 year of age because of inadequate data to establish recommended daily allowances (RDAs) in this age group.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;153&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Infants &lt;6 Months of Age:</p><p>AI of 200 mg daily (presumed to be met by human milk).&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;153&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Infants 6–12 Months of Age:</p><p>AI of 260 mg daily (taking into account additional intake of calcium from food).&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;153&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Children 1–3 Years of Age:</p><p>RDA of 700 mg daily.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;153&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Children 4–8 Years of Age:</p><p>RDA of 1 g daily.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;153&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Children 9–18 Years of Age:</p><p>RDA of 1.3 g daily.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;153&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium gluconate usually is administered IV as a 10% solution and calcium chloride as a 2–10% solution.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;j&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium replacement requirements can be estimated by clinical condition and/or serum calcium determinations.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Neonates: Usually, 50–150 mg/kg of elemental calcium daily; do not exceed 1 g daily.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Children: Usually, 45–65 mg/kg of elemental calcium daily.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Infants: &lt;0.93 mEq of calcium; may be repeated every 1–3 days depending on the patient’s response.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;140&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;141&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Children: Usually, initial dose of 0.93–2.3 mEq of calcium; may be repeated every 1–3 days depending on the patient’s response.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;140&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;141&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Alternatively, one manufacturer recommends a pediatric IV calcium dose of 0.272 mEq/kg, up to a maximum total daily dosage of 1.36–13.6 mEq, in the treatment of hypocalcemic disorders.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;138&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Neonates: May be treated with divided doses of calcium totaling about 2.4 mEq/kg daily.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Children: Usually, calcium dose of 0.5–0.7 mEq/kg administered IV 3 or 4 times daily or until tetany is controlled.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Neonates: 0.45 mEq of calcium concurrently with each 100 mL of citrated blood.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>If calcium is indicated during pediatric resuscitation for treatment of hypocalcemia, calcium-channel blocker overdosage, hypermagnesemia, or hyperkalemia, experts recommend a dose of 0.272 mEq/kg administered slowly using calcium chloride.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;403&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; In critically ill children, calcium chloride may provide a greater increase in ionized calcium than calcium gluconate.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;403&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium replacement requirements can be estimated by clinical condition and/or serum calcium determinations.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Prophylactic administration of calcium supplements may be necessary in some patients in order to maintain serum calcium &gt;9 mg/dL.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>The RDAs of elemental calcium for healthy adults are:</p><p>Adults 19–50 Years of Age:</p><p>RDA of 1 g daily.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;153&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Adults 51–70 Years of Age:</p><p>Men 51–71 years of age: RDA of 1 g daily.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;153&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Women 51–70 years of age: RDA of 1.2 g daily.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;153&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Adults &gt;70 Years of Age:</p><p>RDA of 1.2 g daily.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;153&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Pregnant or Lactating Women:</p><p>Generally, the usual RDA of calcium appropriate for their age.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;153&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium gluconate usually is administered IV as a 10% solution and calcium chloride as a 2–10% solution.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;j&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium replacement requirements can be estimated by clinical condition and/or serum calcium determinations.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Usually, about 1 g of elemental calcium daily.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Usually, 1–2 g or more of elemental calcium daily.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Usually, 0.8 mEq of calcium as the calcium glycerophosphate and calcium lactate fixed-combination preparation 1–4 times weekly or as directed by a clinician.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;142&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Usual initial dose of 2.3–14 mEq of calcium; doses may be repeated every 1–3 days depending on the patient’s response.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;136&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;137&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;138&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;139&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;140&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;141&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>4.5–16 mEq doses of calcium, administered until therapeutic response occurs.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>About 1.35 mEq of calcium concurrently with each 100 mL of citrated blood.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>If calcium is necessary during cardiac arrest, a dose of 0.109–0.218 mEq/kg (repeated as necessary) using calcium chloride has been recommended.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;175&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; Alternatively, 7–14 mEq of calcium as calcium chloride has been given.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; However, routine use not recommended.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;400&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;401&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;403&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; (See Uses.)</p><p>Usual initial dose of 1.334 g of calcium acetate (338 mg of calcium) with each meal;&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; increase dosage gradually according to serum phosphate concentrations, provided hypercalcemia does not occur.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Manufacturer states that most patients require about 2–2.67 g (about 500–680 mg of calcium) with each meal.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; However, some experts recommend limiting dosage of calcium provided by phosphate binders to ≤1.5 g daily and limiting total calcium intake (including dietary calcium) to ≤2 g daily; dialysis patients who remain hyperphosphatemic despite such therapy should receive a calcium-containing phosphate binder in combination with a non-calcium-, non-aluminum-, non-magnesium-containing phosphate binder.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;130&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Monitor serum calcium concentrations twice weekly during initiation of therapy and subsequent dosage adjustment; also monitor serum phosphorus concentrations periodically.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>If hypercalcemia occurs, reduce dosage or withhold the salt.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; If severe hypercalcemia occurs, specific measures (e.g., hemodialysis) for the management of overdosage may be necessary.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Usually, 0.25 mEq/kg of calcium per hour for a 3-hour period; serum gastrin concentrations are determined 30 minutes before the infusion, at the start of the infusion, and at 30-minute intervals thereafter for 4 hours.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>In most patients with Zollinger-Ellison syndrome, preinfusion serum gastrin concentrations increase by more than 50% or by greater than 500 pg/mL during the infusion.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Initially, 7 mEq of calcium; adjust subsequent doses according to patient response.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Usually, about 7 mEq of calcium over 5–10 minutes; in patients with medullary thyroid carcinoma, plasma calcitonin concentrations are elevated above normal basal concentrations.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>For prevention and treatment of osteoporosis, the National Osteoporosis Foundation recommends a calcium intake of 1 g daily in men 50–70 years of age, and a calcium intake of 1.2 g daily in women ≥51 years of age and men ≥71 years of age.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;147&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Special Populations</h3><p>No specific dosage recommendations for hepatic impairment.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;a&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;c&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>No specific dosage recommendations for renal impairment.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;a&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;c&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>No specific geriatric dosage recommendations.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;a&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h2 class="ddc-anchor-offset" id="cautions">Cautions for Calcium Salts</h2><h3>Contraindications</h3><ul>
<li>
<p>Ventricular fibrillation.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
<li>
<p>Hypercalcemia.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
<li>
<p>Hypophosphatemia.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
<li>
<p>Renal calculi.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
<li>
<p>IV administration contraindicated when serum calcium concentrations are above normal.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
</ul><p>Ventricular fibrillation.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Hypercalcemia.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Hypophosphatemia.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Renal calculi.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>IV administration contraindicated when serum calcium concentrations are above normal.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Warnings/Precautions</h3><p>Use calcium salts cautiously, if at all, in sarcoidosis,&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; renal or cardiac disease,&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; or patients receiving cardiac glycosides (see Digoxin under Interactions).&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Because it is acidifying, use calcium chloride cautiously in cor pulmonale,&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; respiratory acidosis,&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; renal disease,&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; or respiratory failure.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Non-lipid-soluble drugs (e.g., calcium) may injure the airway; avoid endotracheal administration.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;403&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Frequently perform determinations of serum calcium concentrations.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Maintain serum calcium concentrations at 9–10.4 mg/dL (4.5–5.2 mEq/L).&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; Some clinicians prefer to maintain serum calcium at slightly lower concentrations.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Usually, do not allow serum calcium concentrations to exceed 12 mg/dL.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Determinations of urine calcium are generally unreliable and hypercalciuria can occur in the presence of hypocalcemia.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; Forcing fluids may produce increased urine volume and thus prevent the formation of renal stones in patients with hypercalciuria.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Administration of calcium in patients who have received transfusions of citrated blood may result in higher than normal total serum calcium concentrations.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; In these patients, however, most of the excess calcium is bound to citrate and is inactive; therefore, serious toxicity usually does not result.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Discontinuing calcium when hypercalcemia occurs usually is sufficient to return serum calcium concentrations to normal.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium salts are irritating to tissue when administered by IM or sub-Q injection and cause mild to severe local reactions including burning, necrosis and sloughing of tissue, cellulitis, and soft tissue calcification; venous irritation may occur with IV administration.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; (See IV Administration and also see IM or Sub-Q Injection, under Dosage and Administration.)</p><p>Extravasation of calcium solution into surrounding tissues during IV injection can cause necrosis.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Patients may complain of tingling sensations, a sense of oppression or heat waves, and a calcium or chalky taste following IV administration of calcium salts.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Rapid IV injection of calcium salts may cause vasodilation, decreased BP, bradycardia, cardiac arrhythmias, syncope, and cardiac arrest.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Inadvertent injection of calcium into the myocardium during attempted intracardiac injection into the ventricular cavity can result in lacerated coronary arteries, cardiac tamponade or pneumothorax, and intractable ventricular fibrillation may result.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Orally administered calcium salts may be irritating to the GI tract.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium salts are constipating.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium chloride, by any route of administration, produces more irritation than the other calcium salts and has been reported to cause GI hemorrhage when taken orally.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Hypercalcemia is rarely produced by administration of calcium alone, but may occur with large doses in patients with chronic renal failure.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Avoid overtreatment of hypocalcemia since hypercalcemia may be more dangerous than hypocalcemia.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Mild hypercalcemia may be asymptomatic or manifest as constipation, anorexia, nausea, and vomiting, with mental changes such as confusion, delirium, stupor, and coma becoming evident as the degree of hypercalcemia increases.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Mild hypercalcemia usually is readily controlled by reducing calcium intake (e.g., decreasing the dose of or avoiding supplemental calcium); more severe hypercalcemia may require specific management (e.g., hemodialysis).&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Dialysis patients with chronic renal failure receiving calcium salts may require adjustments in calcium concentrations in the dialysate to reduce the risk of hypercalcemia.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;126&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Long-term effects of chronic calcium administration (e.g., for hyperphosphatemia in chronic renal failure) on progression of vascular or soft-tissue calcification is unknown.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;127&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>High dietary intake of calcium has long been suspected as contributing to the risk of renal calculi, and restriction of calcium intake (i.e., low-calcium diets) had long been considered a reasonable measure in an attempt to prevent calculi formation in patients with idiopathic hypocalciuria.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;122&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;123&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;124&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Recent evidence indicates that high <i>dietary</i> intake of calcium actually <i>decreases</i> the risk of symptomatic renal calculi, while intake of <i>supplemental</i> calcium <i>may increase</i> the risk of symptomatic stones.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;122&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;123&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;124&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>When used in fixed combination with other agents, consider the cautions, precautions, and contraindications associated with the concomitant agents.</p><p>Category C.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;c&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;i&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Manufacturers state that it is not known whether calcium salts are distributed into milk,&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;a&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;c&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; and to observe caution with parenteral therapy.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;c&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium is an important component of human milk in women not receiving supplemental calcium salts,&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; and maternal calcium supplementation does not substantially affect milk calcium concentrations since the principal source is from maternal bone resorption.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Give calcium cautiously to children by IV route.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;PDH&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium absorption (after oral administration) may be decreased in geriatric patients.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;PDH&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Common Adverse Effects</h3><p>Constipation, nausea, vein irritation.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;PDH&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h2 class="ddc-anchor-offset" id="interactions">Interactions for Calcium Salts</h2><p>Consider the possibility that other drug interactions reported with antacids could occur.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;k&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Specific Drugs and Laboratory Tests</h3><p>Drug or Test</p><p>Interaction</p><p>Comments</p><p>Bisphosphonates, oral (e.g., alendronate, etidronate, ibandronate, risedronate)</p><p>Concomitant administration may result in reduced bisphosphonate absorption&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;150&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Separate administration of the drugs&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;150&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Digoxin</p><p>Inotropic and toxic effects are synergistic and arrhythmias may occur (particularly when calcium is given IV)&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Iron preparations, oral</p><p>Concomitant administration may result in reduced iron absorption&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;149&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Advise patients to take the drugs at different times, whenever possible&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;149&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Levothyroxine</p><p>Calcium carbonate may form insoluble chelate with levothyroxine, resulting in decreased levothyroxine absorption and increased serum thyrotropin concentrations&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;143&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Administer oral levothyroxine and calcium carbonate ≥4 hours apart&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;143&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Quinolones</p><p>Concomitant administration of calcium salts and some fluoroquinolones (e.g., ciprofloxacin) may reduce oral bioavailability of the fluoroquinolone&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;151&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;152&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Recommended timing of fluoroquinolone administration relative to the calcium dose may vary depending on the specific fluoroquinolone preparation used&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;151&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;152&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Test, corticosteroids (Glenn-Nelson technique)</p><p>Transient elevations of plasma 11-hydroxycorticosteroid concentrations with IV calcium, but concentrations return to control values after 1 hour&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Test, magnesium (serum and urine)</p><p>False-negative values as measured by the Titan yellow method&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Tetracyclines</p><p>Calcium complexes tetracycline antibiotics rendering them inactive&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Do not give the 2 drugs together orally nor should they be mixed for parenteral administration&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Thiazide diuretics</p><p>Risk of hypercalcemia&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;PDH&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Avoid concomitant use&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;PDH&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h2 class="ddc-anchor-offset" id="pharmacokinetics">Calcium Salts Pharmacokinetics</h2><h3>Absorption</h3><p>Oral bioavailability of calcium from nonfood sources and supplements depends on intestinal pH, the presence or absence of a meal, and the dose.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium is actively absorbed in the duodenum and proximal jejunum and, to a lesser extent, in the more distal segments of the small intestine.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Degree of absorption depends on a number of factors; absorption from the intestine is never complete.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Absorption requires a soluble, ionized form.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>An acidic intestinal pH is necessary for ionization of calcium; thus an alkaline pH impedes absorption.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Vitamin D, in its activated forms, is required for calcium absorption and increases the capability of the absorptive mechanisms.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Decreased absorption with hypocalcemia secondary to deficiency of either parathyroid hormone or vitamin D.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>IM or IV administered calcium salts are absorbed directly into the blood stream.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Glucocorticoids and low serum concentrations of calcitonin may depress calcium absorption.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>When a 250-mg dose of calcium is administered with a standardized breakfast, average oral bioavailability in adults ranges from 25–35% with various salts; under the same conditions, absorption from milk is about 29%.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Extent of calcium absorption from supplements is greatest when taken in doses ≤500 mg.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium absorption is decreased in the absence of a meal.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium absorption is retarded by certain anions (e.g., oxalates, phytates, sulfates) and by fatty acids which precipitate or complex calcium ions; however, an intestinal pH of 5–7 facilitates maximal dissolution and dissociation of these complexes.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium may be poorly absorbed from foods rich in oxalic acid (e.g., spinach, sweet potatoes, rhubarb, beans) or phytic acid (e.g., unleavened bread, raw beans, seeds, nuts, grains, soy isolates).&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Although soybeans contain high concentrations of phytic acid, calcium absorption is relatively high from this food.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Following IV injection of calcium salts, serum calcium concentrations increase almost immediately and may return to previous values in 30 minutes to 2 hours.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Normal <i>total</i> serum calcium concentrations range from 9–10.4 mg/dL (4.5–5.2 mEq/L), but only <i>ionized</i> calcium is physiologically active.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Serum calcium concentrations are not necessarily accurate indications of total body calcium; total body calcium may be decreased in the presence of hypercalcemia, and hypocalcemia can occur even though total body calcium is increased.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Of <i>total</i> serum calcium concentration, 50% is in the <i>ionic</i> form and 5% is <i>complexed</i> by phosphates, citrates, and other anions.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Hyperproteinemia is associated with increased total serum calcium concentrations.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Hypoproteinemia is associated with decreased total serum calcium concentrations.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Acidosis results in increased concentrations of <i>ionic</i> calcium, while alkalosis promotes a decrease in the <i>ionic</i> serum calcium concentration.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Fractional calcium absorption varies with age as follows:</p><p>Infancy: about 60%.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Children, prepubertal: about 28%.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Early puberty: about 34%.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Young adults: about 25%, although it increases during the last 2 trimesters of pregnancy.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Fractional absorption declines with aging, decreasing on average by 0.21% annually in postmenopausal women.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; Similar declines with aging in men.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Absorption is decreased in certain disease states such as achlorhydria, renal osteodystrophy, steatorrhea, or uremia.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Efficiency of intestinal calcium absorption may be increased when calcium intake is reduced and during pregnancy&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; but not lactation (maternal bone resorption is principal source)&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; when calcium requirements are higher than normal.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Distribution</h3><p>CSF concentrations of calcium are about 50% of serum concentrations and tend to reflect ionized serum calcium concentrations.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium enters extracellular fluid and is incorporated rapidly into skeletal tissue.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; Bone contains 99% of total calcium; 1% is distributed equally between the intracellular and extracellular fluids.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Following absorption, calcium first enters the extracellular fluid and is then rapidly incorporated into skeletal tissue.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Bone formation is not stimulated by calcium administration.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Approximately 45%; for a change in serum albumin of 1 g/dL, serum calcium concentration may change about 0.8 mg/dL (0.04 mEq/dL).&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium crosses the placenta; reaches higher concentrations in fetal than maternal blood.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium is distributed into milk.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Elimination</h3><p>Excreted mainly in the feces as unabsorbed calcium and that secreted via bile and pancreatic juice into the GI tract lumen.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Most of the calcium filtered by renal glomeruli is reabsorbed in the ascending limb of the loop of Henle and proximal and distal convoluted tubules.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; Only small amounts of the cation are excreted in urine.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Parathyroid hormone, vitamin D, and thiazide diuretics decrease urinary excretion of calcium, whereas other diuretics, calcitonin, and growth hormone promote renal excretion of the cation.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Urinary excretion decreases with reduction of ionic serum concentrations but is proportionately increased as serum ionized concentrations increase.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>In healthy adults on a regular diet, urinary excretion of calcium may be as high as 250–300 mg daily.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; With low calcium diets, urinary excretion usually does not exceed 150 mg daily.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium also is excreted by the sweat glands.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Urinary excretion of calcium decreases during pregnancy and in the early stages of renal failure.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Urinary excretion decreases with aging, possibly because of age-related decreases in intestinal calcium absorption efficiency and an associated decrease in filtered calcium load.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Endogenous fecal calcium excretion does not change appreciably with aging.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h2>Stability</h2><h3>Storage</h3><p>25°C (may be exposed to 15–30°C).&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;i&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Tight container at 15–30°C.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;f&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Cool, dry place at 15–30°C.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;e&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>15–30°C; do not freeze.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;a&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;c&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;j&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h3>Compatibility</h3><p>For information on systemic interactions resulting from concomitant use, see Interactions.</p><p>Interaction of calcium and phosphate in parenteral nutrition solutions is a complex phenomenon; various factors have been identified as playing a role in solubility or precipitation of a given combination.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;135&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; Calcium salts are conditionally compatible with phosphate in parenteral nutrition solutions; incompatibility dependent on a solubility and concentration phenomenon and not entirely predictable.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;135&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; Precipitation may occur during compounding or at some time after compounding is completed.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;135&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; Consult specialized references for specific stability and compatibility information.</p><p>Incompatible</p><p>Fat emulsion 10%, IV</p><p>Compatible</p><p>Amikacin sulfate</p><p>Ascorbic acid injection</p><p>Chloramphenicol sodium succinate</p><p>Dopamine HCl</p><p>Hydrocortisone sodium succinate</p><p>Isoproterenol HCl</p><p>Lidocaine HCl</p><p>Norepinephrine bitartrate</p><p>Penicillin G potassium</p><p>Penicillin G sodium</p><p>Pentobarbital sodium</p><p>Phenobarbital sodium</p><p>Verapamil HCl</p><p>Incompatible</p><p>Amphotericin B</p><p>Ceftriaxone sodium</p><p>Magnesium sulfate</p><p>Variable</p><p>Dobutamine HCl</p><p>Sodium bicarbonate</p><p>Compatible</p><p>Amiodarone HCl</p><p>Ceftaroline fosamil</p><p>Dobutamine HCl</p><p>Doxapram HCl</p><p>Epinephrine HCl</p><p>Esmolol HCl</p><p>Hydroxyethyl starch 130/0.4 in sodium chloride 0.9%</p><p>Micafungin sodium</p><p>Milrinone lactate</p><p>Morphine sulfate</p><p>Paclitaxel</p><p>Sodium nitroprusside</p><p>Incompatible</p><p>Amphotericin B cholesteryl sulfate complex</p><p>Propofol</p><p>Sodium bicarbonate</p><p>Compatible</p><p>Alcohol 5%, dextrose 5%</p><p>Amino acids 4%, dextrose 25%</p><p>Dextrose 5% in Ringer’s injection, lactated</p><p>Dextrose 5% in sodium chloride 0.9%</p><p>Dextrose 5% in water</p><p>Dextrose 10% in sodium chloride 0.18%</p><p>Dextrose 10 or 20% in water</p><p>Fructose 10% in water</p><p>Invert sugar 10% in Electrolyte #1 or #2</p><p>Polysal M with dextrose 5%</p><p>Ringer’s injection, lactated</p><p>Sodium chloride 0.9%</p><p>Sodium lactate 1/6 M</p><p>Incompatible</p><p>Fat emulsion 10%, IV</p><p>Compatible</p><p>Amikacin sulfate</p><p>Aminophylline</p><p>Ascorbic acid injection</p><p>Chloramphenicol sodium succinate</p><p>Furosemide</p><p>Heparin sodium</p><p>Hydrocortisone sodium succinate</p><p>Lidocaine HCl</p><p>Norepinephrine bitartrate</p><p>Penicillin G potassium</p><p>Penicillin G sodium</p><p>Phenobarbital sodium</p><p>Potassium chloride</p><p>Prochlorperazine edisylate</p><p>Tobramycin sulfate</p><p>Vancomycin HCl</p><p>Verapamil HCl</p><p>Incompatible</p><p>Amphotericin B</p><p>Ceftriaxone sodium</p><p>Dobutamine HCl</p><p>Methylprednisolone sodium succinate</p><p>Variable</p><p>Magnesium sulfate</p><p>Compatible</p><p>Aldesleukin</p><p>Allopurinol sodium</p><p>Amifostine</p><p>Amiodarone HCl</p><p>Aztreonam</p><p>Bivalirudin</p><p>Cefazolin sodium</p><p>Ceftaroline fosamil</p><p>Ciprofloxacin</p><p>Cisatracurium besylate</p><p>Cladribine</p><p>Dexmedetomidine HCl</p><p>Dobutamine HCl</p><p>Docetaxel</p><p>Doripenem</p><p>Doxapram HCl</p><p>Doxorubicin HCl liposome injection</p><p>Enalaprilat</p><p>Epinephrine HCl</p><p>Etoposide phosphate</p><p>Famotidine</p><p>Fenoldopam mesylate</p><p>Filgrastim</p><p>Gemcitabine HCl</p><p>Granisetron HCl</p><p>Heparin sodium with hydrocortisone sodium succinate</p><p>Hetastarch in lactated electrolyte injection (Hextend)</p><p>Hydroxyethyl starch 130/0.4 in sodium chloride 0.9%</p><p>Labetalol HCl</p><p>Linezolid</p><p>Melphalan HCl</p><p>Micafungin sodium</p><p>Midazolam HCl</p><p>Milrinone lactate</p><p>Nicardipine HCl</p><p>Oxaliplatin</p><p>Piperacillin sodium–tazobactam sodium</p><p>Potassium chloride</p><p>Prochlorperazine edisylate</p><p>Propofol</p><p>Remifentanil HCl</p><p>Sargramostim</p><p>Tacrolimus</p><p>Telavancin HCl</p><p>Teniposide</p><p>Thiotepa</p><p>Vinorelbine tartrate</p><p>Incompatible</p><p>Amphotericin B cholesteryl sulfate complex</p><p>Fluconazole</p><p>Indomethacin sodium trihydrate</p><p>Pemetrexed disodium</p><p>Variable</p><p>Ampicillin sodium</p><p>Meropenem</p><h2>Actions</h2><ul>
<li>
<p>Calcium is essential for maintenance of the functional integrity of nervous, muscular, and skeletal systems and cell-membrane and capillary permeability.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
<li>
<p>Calcium is an important activator in many enzymatic reactions and essential to a number of physiologic processes including transmission of nerve impulses; contraction of cardiac, smooth, and skeletal muscles; renal function; respiration; and blood coagulation.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
<li>
<p>Calcium plays regulatory roles in the release and storage of neurotransmitters and hormones, in the uptake and binding of amino acids, and in cyanocobalamin (vitamin B<sub>12</sub>) absorption and gastrin secretion.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
<li>
<p>Calcium accounts for 1–2% of adult body weight, and more than 99% of total body calcium is found in bone and teeth.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
<li>
<p>Calcium is present in blood, extracellular fluid, muscle, and other tissues where it has roles in mediating vascular contraction and vasodilation, muscle contraction, nerve transmission, and glandular secretion.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
<li>
<p>Skeleton serves as a reservoir for calcium in addition to serving as a structural support for the body.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
<li>
<p>Conditions associated with reduced concentrations of circulating estrogen alter calcium homeostasis.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
<li>
<p>Reduced estrogen concentrations are associated with reduced calcium absorption efficiency and increased bone turnover rates.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
</ul><p>Calcium is essential for maintenance of the functional integrity of nervous, muscular, and skeletal systems and cell-membrane and capillary permeability.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium is an important activator in many enzymatic reactions and essential to a number of physiologic processes including transmission of nerve impulses; contraction of cardiac, smooth, and skeletal muscles; renal function; respiration; and blood coagulation.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium plays regulatory roles in the release and storage of neurotransmitters and hormones, in the uptake and binding of amino acids, and in cyanocobalamin (vitamin B<sub>12</sub>) absorption and gastrin secretion.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium accounts for 1–2% of adult body weight, and more than 99% of total body calcium is found in bone and teeth.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Calcium is present in blood, extracellular fluid, muscle, and other tissues where it has roles in mediating vascular contraction and vasodilation, muscle contraction, nerve transmission, and glandular secretion.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Skeleton serves as a reservoir for calcium in addition to serving as a structural support for the body.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Conditions associated with reduced concentrations of circulating estrogen alter calcium homeostasis.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Reduced estrogen concentrations are associated with reduced calcium absorption efficiency and increased bone turnover rates.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><h2 class="ddc-anchor-offset" id="patient-advice">Advice to Patients</h2><ul>
<li>
<p>Advise patients of the importance of dosage compliance, adherence to instructions about diet, and avoidance of concomitant use of antacids or other preparations containing clinically important concentrations of calcium.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;127&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;i&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;PDH&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
<li>
<p>Advise patients of importance of taking calcium with meals or milk for maximum absorption.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
<li>
<p>Advise patients that daily supplemental intake &gt;2 g is unlikely to provide additional benefit.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;h&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
<li>
<p>Advise patients of potential manifestations of hypercalcemia.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
<li>
<p>Warn patients not to use bone meal or dolomite as a source of calcium; they may contain lead.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;PDH&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
<li>
<p>Importance of informing clinicians of existing or contemplated concomitant therapy, including prescription and OTC drugs.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;a&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
<li>
<p>Importance of women informing clinicians if they are or plan to become pregnant or plan to breast-feed.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;a&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p>
</li>
<li>
<p>Importance of informing patients of other important precautionary information.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;a&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;j&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; (See Cautions.)</p>
</li>
</ul><p>Advise patients of the importance of dosage compliance, adherence to instructions about diet, and avoidance of concomitant use of antacids or other preparations containing clinically important concentrations of calcium.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;127&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;i&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;PDH&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Advise patients of importance of taking calcium with meals or milk for maximum absorption.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;112&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Advise patients that daily supplemental intake &gt;2 g is unlikely to provide additional benefit.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;h&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Advise patients of potential manifestations of hypercalcemia.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;113&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Warn patients not to use bone meal or dolomite as a source of calcium; they may contain lead.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;PDH&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Importance of informing clinicians of existing or contemplated concomitant therapy, including prescription and OTC drugs.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;a&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Importance of women informing clinicians if they are or plan to become pregnant or plan to breast-feed.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;a&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt;</p><p>Importance of informing patients of other important precautionary information.&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;a&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; &lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;sup&gt;j&lt;/sup&gt;&lt;/body&gt;&lt;/html&gt; (See Cautions.)</p><h2 class="ddc-anchor-offset" id="preparations">Preparations</h2><p><i>Excipients in commercially available drug preparations may have clinically important effects in some individuals; consult specific product labeling for details.</i></p><p><i>Please refer to the ASHP Drug Shortages Resource Center for information on shortages of one or more of these preparations.</i></p><p>* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name</p><p>Routes</p><p>Dosage Forms</p><p>Strengths</p><p>Brand Names</p><p>Manufacturer</p><p>Bulk</p><p>Powder*</p><p>Calcium Acetate Powder</p><p>Oral</p><p>Capsules</p><p>667 mg (169 mg calcium; 8.45 mEq of Ca<sup>++</sup>)*</p><p>Calcium Acetate Capsules</p><p>PhosLo<sup></sup> GelCaps</p><p>Fresenius</p><p>* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name</p><p>Routes</p><p>Dosage Forms</p><p>Strengths</p><p>Brand Names</p><p>Manufacturer</p><p>Bulk</p><p>Powder*</p><p>Calcium Carbonate, Precipitated Powder</p><p>Oral</p><p>Capsules</p><p>1.25 g (500 mg calcium)</p><p>Calcium Carbonate, Precipitated Calci-Mix<sup></sup></p><p>Watson</p><p>Capsules, liquid-filled</p><p>600 mg (240 mg of calcium)</p><p>Liqui-Cal<sup></sup> Softgels<sup></sup></p><p>Advanced Nutritional Technology</p><p>Suspension</p><p>1.25 g (500 mg calcium) per 5 mL*</p><p>Calcium Carbonate Suspension</p><p>Tablets</p><p>650 mg (260 mg calcium)*</p><p>Calcium Carbonate Tablets</p><p>1.25 g (500 mg calcium)*</p><p>Calcium Carbonate Tablets</p><p>Os-Cal<sup></sup> 500</p><p>GlaxoSmithKline</p><p>Tablets, chewable</p><p>420 mg (168 mg calcium)</p><p>Titralac<sup></sup></p><p>3M</p><p>500 mg (200 mg calcium)</p><p>Chooz<sup></sup></p><p>Insight</p><p>Tums<sup></sup></p><p>GlaxoSmithKline</p><p>750 mg (300 mg calcium)</p><p>Tums E-X<sup></sup> 750</p><p>GlaxoSmithKline</p><p>850 mg (340 mg calcium)</p><p>Alka-Mints<sup></sup></p><p>Bayer</p><p>1 g (400 mg calcium)</p><p>Tums<sup></sup> Ultra 1000</p><p>GlaxoSmithKline</p><p>1.25 g (500 mg calcium)*</p><p>Calcium Carbonate Chewable Tablets</p><p>Calci-Chew<sup></sup></p><p>Watson</p><p>Os-Cal<sup></sup> 500</p><p>GlaxoSmithKline</p><p>Tablets, film-coated</p><p>1.5 g (600 mg calcium)*</p><p>Calcium Carbonate Tablets</p><p>Caltrate<sup></sup> 600</p><p>Wyeth</p><p>* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name</p><p>Routes</p><p>Dosage Forms</p><p>Strengths</p><p>Brand Names</p><p>Manufacturer</p><p>Oral</p><p>Pieces, chewable</p><p>1.25 g (500 mg calcium) with Cholecalciferol 100 units and Phytonadione 40 mcg</p><p>Viactiv<sup></sup> Soft Calcium Chews</p><p>McNeil</p><p>Tablets</p><p>Calcium Carbonate 240 mg with Calcium Gluconate 240 mg, Calcium Lactate 240 mg (152.8 mg calcium), and Cholecalciferol 100 units</p><p>Calcet<sup></sup></p><p>Mission</p><p>1.25 g (500 mg calcium) with Cholecalciferol 200 units*</p><p>Calcium Carbonate, Precipitated, and Cholecalciferol Tablets</p><p>Os-Cal<sup></sup> 500+D</p><p>GlaxoSmithKline</p><p>1.5 g (600 mg calcium) with Cholecalciferol 125 units*</p><p>Calcium Carbonate, Precipitated, and Cholecalciferol Tablets</p><p>1.5 g (600 mg calcium) with Cholecalciferol 280 units*</p><p>Calcium Carbonate, Precipitated, and Cholecalciferol Tablets</p><p>Healthy Woman<sup></sup> (scored)</p><p>Personal Products</p><p>Tablets, film-coated</p><p>1.5 g (600 mg calcium) with Cholecalciferol 400 units</p><p>Caltrate<sup></sup> 600 + Vitamin D</p><p>Wyeth</p><p>* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name</p><p>Routes</p><p>Dosage Forms</p><p>Strengths</p><p>Brand Names</p><p>Manufacturer</p><p>Bulk</p><p>Powder*</p><p>Calcium Chloride Powder</p><p>Parenteral</p><p>Injection</p><p>10% (1.36–1.4 mEq of Ca<sup>++</sup> and Cl<sup>−</sup> per mL)*</p><p>Calcium Chloride Injection</p><p>Routes</p><p>Dosage Forms</p><p>Strengths</p><p>Brand Names</p><p>Manufacturer</p><p>Oral</p><p>Tablets</p><p>950 mg (200 mg calcium)</p><p>Citracal<sup></sup></p><p>Bayer</p><p>Routes</p><p>Dosage Forms</p><p>Strengths</p><p>Brand Names</p><p>Manufacturer</p><p>Oral</p><p>Tablets</p><p>1.5 g (315 mg calcium) with Cholecalciferol 250 units</p><p>Citracal<sup></sup> + D Caplets<sup></sup></p><p>Bayer</p><p>* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name</p><p>Routes</p><p>Dosage Forms</p><p>Strengths</p><p>Brand Names</p><p>Manufacturer</p><p>Bulk</p><p>Powder*</p><p>Calcium Gluceptate Powder</p><p>* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name</p><p>Routes</p><p>Dosage Forms</p><p>Strengths</p><p>Brand Names</p><p>Manufacturer</p><p>Bulk</p><p>Powder*</p><p>Calcium Gluconate Powder</p><p>Oral</p><p>Tablets</p><p>500 mg (45 mg calcium)*</p><p>Calcium Gluconate Tablets</p><p>650 mg (58.5 mg calcium)*</p><p>Calcium Gluconate Tablets</p><p>1 g (90 mg calcium)*</p><p>Calcium Gluconate Tablets</p><p>Parenteral</p><p>Injection</p><p>10% (0.45–0.48 mEq of Ca<sup>++</sup> per mL provided by calcium gluconate and other calcium salt stabilizers)*</p><p>Calcium Gluconate Injection</p><p>Injection, for preparation of IV admixtures</p><p>10% (0.45–0.48 mEq of Ca<sup>++</sup> per mL provided by calcium gluconate and calcium saccharate or other calcium salts stabilizers) pharmacy bulk package*</p><p>Calcium Gluconate Injection Pharmacy Bulk Package</p><p>* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name</p><p>Routes</p><p>Dosage Forms</p><p>Strengths</p><p>Brand Names</p><p>Manufacturer</p><p>Bulk</p><p>Powder*</p><p>Calcium Glycerophosphate Powder</p><p>Routes</p><p>Dosage Forms</p><p>Strengths</p><p>Brand Names</p><p>Manufacturer</p><p>Parenteral</p><p>Injection</p><p>0.08 mEq of Ca<sup>++</sup> (provided by calcium glycerophosphate 5 mg and calcium lactate 5 mg) per mL</p><p>Calphosan<sup></sup></p><p>Glenwood</p><p>* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name</p><p>Routes</p><p>Dosage Forms</p><p>Strengths</p><p>Brand Names</p><p>Manufacturer</p><p>Bulk</p><p>Powder*</p><p>Calcium Lactate Powder</p><p>Oral</p><p>Tablets</p><p>325 mg (42.25 mg calcium)*</p><p>Calcium Lactate Tablets</p><p>650 mg (84.5 mg calcium)*</p><p>Calcium Lactate Tablets</p><p>* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name</p><p>Routes</p><p>Dosage Forms</p><p>Strengths</p><p>Brand Names</p><p>Manufacturer</p><p>Bulk</p><p>Powder*</p><p>Calcium Phosphate Dibasic Powder</p><p>* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name</p><p>Routes</p><p>Dosage Forms</p><p>Strengths</p><p>Brand Names</p><p>Manufacturer</p><p>Bulk</p><p>Powder*</p><p>Calcium Phosphate Tribasic Powder</p><p>Oral</p><p>Tablets, film-coated</p><p>1.5652 g (600 mg calcium)</p><p>Posture<sup></sup> (scored)</p><p>Inverness</p><p>Routes</p><p>Dosage Forms</p><p>Strengths</p><p>Brand Names</p><p>Manufacturer</p><p>Oral</p><p>Tablets, film-coated</p><p>1.5652 g (600 mg calcium) with Cholecalciferol 125 units</p><p>Posture-D<sup></sup> (scored)</p><p>Inverness</p><p>Calcium salts are also commercially available in combination with vitamins, minerals, electrolytes, and antacids.</p><p>AHFS<sup></sup> DI Essentials™. © Copyright 2021, Selected Revisions January 7, 2019. American Society of Health-System Pharmacists, Inc., 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.</p><p>† Use is not currently included in the labeling approved by the US Food and Drug Administration.</p><h2>References</h2><p>Only references cited for selected revisions after 1984 are available electronically.</p><p>100. National Institutes of Health Office of Medical Applications of Research. Consensus conference: osteoporosis. <i>JAMA</i>. 1984; 252:799-802. http://www.ncbi.nlm.nih.gov/pubmed/6748181?dopt=AbstractPlus</p><p>101. McCarron DA, Morris CD, Cole C. Dietary calcium in human hypertension. <i>Science</i>. 1982; 217:267-9. http://www.ncbi.nlm.nih.gov/pubmed/7089566?dopt=AbstractPlus</p><p>102. McCarron DA, Morris CD, Henry HJ et al. Blood pressure and nutrient intake in the United States. <i>Science</i>. 1984; 224:1392-8. http://www.ncbi.nlm.nih.gov/pubmed/6729459?dopt=AbstractPlus</p><p>103. Kaplan NM. Non-drug treatment of hypertension. <i>Ann Intern Med</i>. 1985; 102:359-73. http://www.ncbi.nlm.nih.gov/pubmed/3882040?dopt=AbstractPlus</p><p>104. Belizan JM, Villar J, Pineda O et al. Reduction of blood pressure with calcium supplementation in young adults. <i>JAMA</i>. 1983; 249:1161-5. http://www.ncbi.nlm.nih.gov/pubmed/6337285?dopt=AbstractPlus</p><p>105. Belizan JM, Villar J, Zalazar A et al. Preliminary evidence of the effect of calcium supplementation on blood pressure in normal pregnant women. <i>Am J Obstet Gynecol</i>. 1983; 146:175-80. http://www.ncbi.nlm.nih.gov/pubmed/6846435?dopt=AbstractPlus</p><p>106. McCarron DA, Morris CD. Blood pressure response to oral calcium in persons with mild to moderate hypertension: randomized, double-blind, placebo-controlled, crossover trial. <i>Ann Intern Med</i>. 1985; 103(6 Part 1): 825-31. http://www.ncbi.nlm.nih.gov/pubmed/3904559?dopt=AbstractPlus</p><p>107. Resnick LM. Calcium and hypertension: the emerging connection. <i>Ann Intern Med</i>. 1985; 103(6 Part 1): 944-6. http://www.ncbi.nlm.nih.gov/pubmed/4062094?dopt=AbstractPlus</p><p>108. Heath H III, Callaway CW. Calcium tablets for hypertension? <i>Ann Intern Med</i>. 1985; 103(6 Part 1): 946-7. Editorial.</p><p>110. National Research Council Subcommittee on the Tenth Edition of the RDAs. Recommended dietary allowances. 10th ed. Washington, DC: National Academy Press; 1989:174-84.</p><p>111. Prince RL, Smith M, Dick IM et al. Prevention of postmenopausal osteoporosis: a comparative study of exercise, calcium supplementation, and hormone-replacement therapy. <i>N Engl J Med</i>. 1991; 325:1189-95. http://www.ncbi.nlm.nih.gov/pubmed/1922205?dopt=AbstractPlus</p><p>112. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes of the Food and Nutrition Board, Institute of Medicine, National Academy of Sciences. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: National Academy Press; 1997. (Uncorrected proofs.)</p><p>113. Braintree Laboratories. PhosLo<sup></sup> (calcium acetate) tablets prescribing information (dated May 1992). In: Physicians’ desk reference. 52nd ed. Montvale, NJ; 1998:733-4.</p><p>115. Allender PS, Cutler JA, Follmann D et al. Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials. <i>Ann Intern Med</i>. 1996; 124:825-31. http://www.ncbi.nlm.nih.gov/pubmed/8610952?dopt=AbstractPlus</p><p>116. National Institutes of Health. Optimum calcium intake. NIH consensus statement 1994 Jun 6–8; 12(4):1-31.</p><p>117. Levine RJ, Hauth JC, Curet LB et al. Trial of calcium to prevent preeclampsia. <i>N Engl J Med</i>. 1997; 337:69-76. http://www.ncbi.nlm.nih.gov/pubmed/9211675?dopt=AbstractPlus</p><p>118. Roberts JM. Prevention and early treatment of preeclampsia. <i>N Engl J Med</i>. 1997; 337:124-5. http://www.ncbi.nlm.nih.gov/pubmed/9211683?dopt=AbstractPlus</p><p>120. Bucher HC, Cook RJ, Guyatt GH et al. Effects of dietary calcium supplementation on blood pressure: a meta-analysis of randomized controlled trials. <i>JAMA</i>. 1996; 275:1016-1022. http://www.ncbi.nlm.nih.gov/pubmed/8596234?dopt=AbstractPlus</p><p>121. McCarron DA, Hatton D. Dietary calcium and lower blood pressure: we all can benefit. <i>JAMA</i>. 1996; 275:1128-9. http://www.ncbi.nlm.nih.gov/pubmed/8601935?dopt=AbstractPlus</p><p>122. Curhan GC, Willett WC, Speizer FE et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. <i>Ann Intern Med</i>. 1997; 126:497-504. http://www.ncbi.nlm.nih.gov/pubmed/9092314?dopt=AbstractPlus</p><p>123. Curhan GC, Willett WC, Rimm EB et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. <i>N Engl J Med</i>. 1993; 328:833-8. http://www.ncbi.nlm.nih.gov/pubmed/8441427?dopt=AbstractPlus</p><p>124. Coe FL, Parks JH, Favus MJ. Diet and calcium: the end of an era? <i>Ann Intern Med</i>. 1997; 126:553-5. Editorial.</p><p>125. Bucher HC, Guyatt GH, Cook RJ et al. Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. <i>JAMA</i>. 1996; 275:1113-7. http://www.ncbi.nlm.nih.gov/pubmed/8601931?dopt=AbstractPlus</p><p>126. European Foundation for Osteoporosis and Bone Disease, National Osteoporosis Foundation, and National Institute of Arthritis and Musculoskeletal and Skin Disease. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. <i>Am J Med</i>. 1993; 94:646-50. http://www.ncbi.nlm.nih.gov/pubmed/8506892?dopt=AbstractPlus</p><p>127. National Institutes of Health Consensus Development Conference Panel. Morbidity and mortolity of renal dialysis: an NIH consensus conference statement. <i>Ann Intern Med</i>. 1994; 121:62-70. http://www.ncbi.nlm.nih.gov/pubmed/8198352?dopt=AbstractPlus</p><p>128. American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Part 10: pediatric advanced life support. <i>Circulation</i>. 2000; 128(Suppl 1):1291-342.</p><p>129. Anon. Drugs for prevention and treatment of postmenopausal osteoporosis. <i>Med Lett Drugs Ther</i>. 2000; 42:97-100. http://www.ncbi.nlm.nih.gov/pubmed/11035622?dopt=AbstractPlus</p><p>130. National Kidney Foundation. Kidney Disease Outcomes Quality Initiative (K/DOQI) clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Guideline 5. Use of phosphate binders in CKD. 2003. Available at http://www.kidney.org/professionals/kdoqi/guidelines_bone/Guide5.htm. Accessed 2005 Mar 22.</p><p>131. Genzyme. Renagel<sup></sup> (sevelamer hydrochloride) capsules and tablets prescribing information. Cambridge, MA; 2000 Jul.</p><p>132. Shire US Inc. Fosrenol<sup></sup> (lanthanum carbonate) chewable tablets prescribing information. Wayne, PA; 2004 Oct.</p><p>133. Loghman-Adham M. Safety of new phosphate binders for chronic renal failure. <i>Drug Saf</i>. 2003; 26:1093-15.</p><p>135. Trissel LA. Handbook on Injectable Drugs. Bethesda, MD: American Society of Health-System Pharmacists.</p><p>136. Hospira. Calcium chloride Abboject<sup></sup> injection prescribing information. Lake Forest, IL; 2004 Oct.</p><p>137. Hospira. Calcium chloride Ansyr<sup></sup> injection prescribing information. Lake Forest, IL; 2004 Jun.</p><p>138. IMS. Calcium chloride injection prescribing information. South El Monte, CA; 2000 Feb.</p><p>139. American Regent. Calcium chloride injection prescribing information. Shirley, NY; 2006 Sep.</p><p>140. APP. Calcium gluconate injection prescribing information. Schaumburg, IL; 2007 Dec.</p><p>141. American Regent. Calcium gluconate injection prescribing information. Shirley, NY; 2000 Feb.</p><p>142. Glenwood, LLC. Calphosan<sup></sup> (calcium lactate/calcium glycerophosphate) injection prescribing information. Englewood, NJ; 2008 Apr. Available at http://www.glenwood-llc.com/pre-calphosan.html. Accessed 2008 Oct 22.</p><p>143. Abbott Laboratories. Synthroid<sup></sup> (levothyroxine sodium) tablets prescribing information. North Chicago, IL; 2008 Mar.</p><p>147. Cosman F, de Beur SJ, LeBoff MS et al. Clinician's Guide to Prevention and Treatment of Osteoporosis. <i>Osteoporos Int</i>. 2014; 25:2359-81. http://www.ncbi.nlm.nih.gov/pubmed/25182228?dopt=AbstractPlus</p><p>148. Watts NB, Bilezikian JP, Camacho PM et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. <i>Endocr Pract</i>. 2010 Nov-Dec; 16 Suppl 3:1-37. http://www.ncbi.nlm.nih.gov/pubmed/21224201?dopt=AbstractPlus</p><p>149. Iron salts/antacids. In: Tatro DS, ed. Drug Interactions Facts. St. Louis, MO: Wolters Kluwer Health; 2008:419.</p><p>150. Rizzoli R, Reginster JY, Boonen S et al. Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. <i>Calcif Tissue Int</i>. 2011; 89:91-104. http://www.ncbi.nlm.nih.gov/pubmed/21637997?dopt=AbstractPlus</p><p>151. Quinolones/antacids. In: Tatro DS, ed. Drug Interactions Facts. St. Louis, MO: Wolters Kluwer Health; 2008:610.</p><p>152. Bayer. Cipro<sup></sup> (ciprofloxacin hydrochloride tablets and ciprofloxacin oral suspension) prescribing information. Wayne, NJ; 2008 Oct.</p><p>153. Institute of Medicine. Dietary reference intakes for adequacy: calcium and vitamin D. In: Ross CA, Taylor CL, Yaktine AL, and Del Valle HB, eds. Dietary reference intakes for calcium and vitamin D. Washington DC: The National Academies Press; 2011:345-402. https://doi.org/10.17226/13050</p><p>175. The American Heart Association. Guidelines 2005 for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2005; 112(Suppl I): IV1-211.</p><p>196. Vanden Hoek TL, Morrison LJ, Shuster M et al. Part 12: cardiac arrest in special situations: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. <i>Circulation</i>. 2010; 122(18 Suppl 3):S829-61.</p><p>400. Link MS, Berkow LC, Kudenchuk PJ et al. Part 7: Adult Advanced Cardiovascular Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. <i>Circulation</i>. 2015; 132(18 Suppl 2):S444-64. http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&amp;artid=4771073&amp;blobtype=pdf</p><p>401. Neumar RW, Otto CW, Link MS et al. Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. <i>Circulation</i>. 2010; 122(18 Suppl 3):S729-67.</p><p>402. de Caen AR, Berg MD, Chameides L et al. Part 12: Pediatric Advanced Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. <i>Circulation</i>. 2015; 132(18 Suppl 2):S526-42. http://www.ncbi.nlm.nih.gov/pubmed/26473000?dopt=AbstractPlus</p><p>403. Kleinman ME, Chameides L, Schexnayder SM et al. Part 14: pediatric advanced life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. <i>Circulation</i>. 2010; 122(18 Suppl 3):S876-908. http://www.pubmedcentral.nih.gov/picrender.fcgi?tool=pmcentrez&amp;artid=3717258&amp;blobtype=pdf</p><p>622. Buckley L, Guyatt G, Fink HA et al. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. <i>Arthritis Rheumatol</i>. 2017; 69:1521-1537. http://www.ncbi.nlm.nih.gov/pubmed/28585373?dopt=AbstractPlus</p><p>a. American Pharmaceutical Partners, Inc. Calcium chloride injection, USP prescribing information. Schaumburg, IL; 2002 Apr.</p><p>b. AHFS Drug Information. McEvoy, GK, ed. Calcium salts. Bethesda, MD: American Society of Health-System Pharmacists.</p><p>c. American Pharmaceutical Partners, Inc. Calcium gluconate injection, USP prescribing information. Schaumburg, IL: 2002 May.</p><p>d. Food and Drug Administration. Antacid products for over-the-counter (OTC) human use. [21 FR Part 331] Fed Regist. 1990; 55:19859.</p><p>e. Rugby Laboratories, Inc. Calcium gluconate supplement patient information. Duluth, GA; 2004 Mar.</p><p>f. Rugby Laboratories, Inc. Calcionate (calcium glubionate) syrup patient information. Duluth, GA; undated.</p><p>g. American Pharmaceutical Partners, Inc. Calcium gluconate injection USP pharmacy bulk package prescribing information. Schaumburg, IL; 2002 May.</p><p>h. GlaxoSmithKline. Os-Cal<sup></sup> 500 calcium supplement patient information. Research Triangle Park, NC; undated.</p><p>i. Nabi Biopharmaceuticals. Phos Lo<sup></sup> (calcium acetate) Gel Caps prescribing information. Boca Raton, FL; 2003 Aug.</p><p>j. American Regent Laboratories, Inc. Calcium chloride injection, USP 10% prescribing information. Shirley, NY; 2000 Feb.</p><p>k. AHFS Drug Information. McEvoy, GK, ed. Antacids. Bethesda, MD: American Society of Health-System Pharmacists.</p><p>PDH. Schilling McCann JA, Publisher. Pharmacists drug handbook. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins and American Society of Health-System Pharmacists; 2003.</p><p>HID. Trissel LA. Handbook on injectable drugs. Bethesda, MD: American Society of Health-System Pharmacists.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>